Administration of exogenous melatonin after the onset of systemic inflammation is hardly beneficial

L Brencher, M Oude Lansink, K Effenberger-Neidnicht - Inflammation, 2017 - Springer
Melatonin improves survival and functional impairment including hemolysis,
thrombocytopenia, and hypotension when administered in a prophylactic manner or early …
被引用次数：7 相关文章

Administration of Exogenous Melatonin After the Onset of Systemic Inflammation Is Hardly Beneficial.

L Brencher, O Lansink, K Effenberger-Neidnicht - Inflammation, 2017 - europepmc.org
Melatonin improves survival and functional impairment including hemolysis,
thrombocytopenia, and hypotension when administered in a prophylactic manner or early …

Administration of Exogenous Melatonin After the Onset of Systemic Inflammation Is Hardly Beneficial

L Brencher, MO Lansink… - Inflammation, 2017 - search.proquest.com
Melatonin improves survival and functional impairment including hemolysis,
thrombocytopenia, and hypotension when administered in a prophylactic manner or early …

Administration of Exogenous Melatonin After the Onset of Systemic Inflammation Is Hardly Beneficial.

L Brencher, M Oude Lansink… - …, 2017 - search.ebscohost.com
Melatonin improves survival and functional impairment including hemolysis,
thrombocytopenia, and hypotension when administered in a prophylactic manner or early …

Administration of Exogenous Melatonin After the Onset of Systemic Inflammation Is Hardly Beneficial

L Brencher, MO Lansink, K Effenberger-Neidnicht - Inflammation, 2017 - infona.pl
Melatonin improves survival and functional impairment including hemolysis,
thrombocytopenia, and hypotension when administered in a prophylactic manner or early …

Administration of Exogenous Melatonin After the Onset of Systemic Inflammation Is Hardly Beneficial

L Brencher, MO Lansink… - …, 2017 - pubmed.ncbi.nlm.nih.gov
Melatonin improves survival and functional impairment including hemolysis,
thrombocytopenia, and hypotension when administered in a prophylactic manner or early …